Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.445 USD | -2.09% | -4.59% | +71.26% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+71.26% | 3.19B | |
+9.44% | 115B | |
+12.76% | 107B | |
-13.33% | 22.31B | |
-3.14% | 21.6B | |
-5.12% | 18.23B | |
-38.57% | 17.62B | |
+7.25% | 14.26B | |
+35.27% | 12.37B | |
-26.67% | 8.28B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Summit Therapeutics Files Mixed Securities Shelf